
DOI . ORG {
}
Title[redir]:
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial | Nature Medicine
Description:
Antibodies targeting PD-1 or its ligand 1 PD-L1 such as atezolizumab, have great efficacy in a proportion of metastatic urothelial cancers1,2. Biomarkers may facilitate identification of these responding tumors3. Neoadjuvant use of these agents is associated with pathological complete response in a spectrum of tumors, including urothelial cancer4–7. Sequential tissue sampling from these studies allowed for detailed on-treatment biomarker analysis. Here, we present a single-arm phase 2 study, investigating two cycles of atezolizumab before cystectomy in 95 patients with muscle-invasive urothelial cancer (ClinicalTrials.gov identifier: NCT02662309 ). Pathological complete response was the primary endpoint. Secondary endpoints focused on safety, relapse-free survival and biomarker analysis. The pathological complete response rate was 31% (95% confidence interval: 21–41%), achieving the primary efficacy endpoint. Baseline biomarkers showed that the presence of preexisting activated T cells was more prominent than expected and correlated with outcome. Other established biomarkers, such as tumor mutational burden, did not predict outcome, differentiating this from the metastatic setting. Dynamic changes to gene expression signatures and protein biomarkers occurred with therapy, whereas changes in DNA alterations with treatment were uncommon. Responding tumors showed predominant expression of genes related to tissue repair after treatment, making tumor biomarker interpretation challenging in this group. Stromal factors such as transforming growth factor-β and fibroblast activation protein were linked to resistance, as was high expression of cell cycle gene signatures after treatment. A single-arm multicenter phase 2 trial demonstrates clinical efficacy of neoadjuvant PD-L1 blockade in patients with resectable muscle-invasive bladder cancer ineligible for cisplatin and examines biomarkers associated with patient outcome.
Matching Content Categories {📚}
- Education
- Science
- Health & Fitness
Content Management System {📝}
What CMS is doi.org built with?
Custom-built
No common CMS systems were detected on Doi.org, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of doi.org audience?
🏙️ Massive Traffic: 50M - 100M visitors per month
Based on our best estimate, this website will receive around 96,105,781 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Doi.org Make Money? {💸}
We don’t know how the website earns money.
The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Doi.org could be secretly minting cash, but we can't detect the process.
Keywords {🔍}
article, cancer, nature, google, scholar, data, patients, cas, urothelial, neoadjuvant, oncology, research, analysis, response, carcinoma, hospital, clinical, study, access, bladder, biomarkers, baseline, tumor, med, medical, medicine, atezolizumab, trial, department, fundinghonoraria, content, metastatic, phase, cells, treatment, chemotherapy, clin, university, extended, samples, information, change, published, biomarker, powles, muscleinvasive, immunotherapy, advanced, nat, immune,
Topics {✒️}
nature portfolio journals permissions reprints nature portfolio privacy policy advertising muscle-invasive bladder cancer muscle-invasive urothelial cancer social media transforming growth factor-β protocol development open-label nature+ nature 554 nature pieter-jan van dam research funding/honoraria european genome-phenome archive alejo rodriguez-vida pd-1/pd-l1 blockade albert font pous cisplatin-based neoadjuvant chemotherapy accession number ega-box-1336 universidad de sevilla pd-1/pd-l1 immunotherapy high-risk resectable melanoma refractory solid tumors platinum-treated locally advanced permissions springerlink instant access barts cancer institute netherlands cancer institute santiago de compostela van der heijden extended data fig advanced urothelial cancers urbano anido herranz maria jose mendez neoadjuvant pd-1 blockade pd-l1 blockade data monitoring committee author correspondence fibroblast activation protein hospital del mar resting memory cells operable urothelial carcinoma gene expression signatures metastatic urothelial carcinoma resectable lung cancer privacy ligand 1 pd-l1
Schema {🗺️}
WebPage:
mainEntity:
headline:Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
description:Antibodies targeting PD-1 or its ligand 1 PD-L1 such as atezolizumab, have great efficacy in a proportion of metastatic urothelial cancers1,2. Biomarkers may facilitate identification of these responding tumors3. Neoadjuvant use of these agents is associated with pathological complete response in a spectrum of tumors, including urothelial cancer4â7. Sequential tissue sampling from these studies allowed for detailed on-treatment biomarker analysis. Here, we present a single-arm phase 2 study, investigating two cycles of atezolizumab before cystectomy in 95 patients with muscle-invasive urothelial cancer (ClinicalTrials.gov identifier:
NCT02662309
). Pathological complete response was the primary endpoint. Secondary endpoints focused on safety, relapse-free survival and biomarker analysis. The pathological complete response rate was 31% (95% confidence interval: 21â41%), achieving the primary efficacy endpoint. Baseline biomarkers showed that the presence of preexisting activated T cells was more prominent than expected and correlated with outcome. Other established biomarkers, such as tumor mutational burden, did not predict outcome, differentiating this from the metastatic setting. Dynamic changes to gene expression signatures and protein biomarkers occurred with therapy, whereas changes in DNA alterations with treatment were uncommon. Responding tumors showed predominant expression of genes related to tissue repair after treatment, making tumor biomarker interpretation challenging in this group. Stromal factors such as transforming growth factor-β and fibroblast activation protein were linked to resistance, as was high expression of cell cycle gene signatures after treatment. A single-arm multicenter phase 2 trial demonstrates clinical efficacy of neoadjuvant PD-L1 blockade in patients with resectable muscle-invasive bladder cancer ineligible for cisplatin and examines biomarkers associated with patient outcome.
datePublished:2019-11-04T00:00:00Z
dateModified:2023-03-21T00:00:00Z
pageStart:1706
pageEnd:1714
sameAs:https://doi.org/10.1038/s41591-019-0628-7
keywords:
Bladder cancer
Predictive markers
Biomedicine
general
Cancer Research
Metabolic Diseases
Infectious Diseases
Molecular Medicine
Neurosciences
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-019-0628-7/MediaObjects/41591_2019_628_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-019-0628-7/MediaObjects/41591_2019_628_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-019-0628-7/MediaObjects/41591_2019_628_Fig3_HTML.png
isPartOf:
name:Nature Medicine
issn:
1546-170X
1078-8956
volumeNumber:25
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Thomas Powles
url:http://orcid.org/0000-0001-7760-4724
affiliation:
name:Queen Mary University of London
address:
name:Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Mark Kockx
affiliation:
name:HistogeneX N.V.
address:
name:HistogeneX N.V., Wilrijk, Belgium
type:PostalAddress
type:Organization
type:Person
name:Alejo Rodriguez-Vida
affiliation:
name:Hospital del Mar
address:
name:Department of Medical Oncology, Hospital del Mar, Barcelona, Spain
type:PostalAddress
type:Organization
type:Person
name:Ignacio Duran
affiliation:
name:IBiS, Hospital Universitario Virgen del Rocio, CSIC and Universidad de Sevilla
address:
name:Instituto de Biomedicina de Sevilla, IBiS, Hospital Universitario Virgen del Rocio, CSIC and Universidad de Sevilla, Seville, Spain
type:PostalAddress
type:Organization
type:Person
name:Simon J. Crabb
url:http://orcid.org/0000-0003-3521-9064
affiliation:
name:University of Southampton
address:
name:Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK
type:PostalAddress
type:Organization
type:Person
name:Michiel S. Van Der Heijden
affiliation:
name:The Netherlands Cancer Institute
address:
name:Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands
type:PostalAddress
type:Organization
type:Person
name:Bernadett Szabados
affiliation:
name:Queen Mary University of London
address:
name:Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK
type:PostalAddress
type:Organization
type:Person
name:Albert Font Pous
affiliation:
name:Hospital Universitari Germans Trias i Pujol
address:
name:Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B.ARGO)-IGTP, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
type:PostalAddress
type:Organization
type:Person
name:Gwenaelle Gravis
affiliation:
name:Institut Paoli-Calmettes
address:
name:Institut Paoli-Calmettes, Marseille, France
type:PostalAddress
type:Organization
type:Person
name:Urbano Anido Herranz
url:http://orcid.org/0000-0003-0376-5642
affiliation:
name:Hospital Clinico Universitario de Santiago
address:
name:Department of Medical Oncology, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain
type:PostalAddress
type:Organization
type:Person
name:Andrew Protheroe
url:http://orcid.org/0000-0001-9413-0575
affiliation:
name:Churchill Hospital
address:
name:Department of Medical Oncology, Churchill Hospital, Oxford, UK
type:PostalAddress
type:Organization
type:Person
name:Alain Ravaud
affiliation:
name:University of BordeauxâCHU Bordeaux
address:
name:Department of Medical Oncology, Hopital Saint-Andre, University of BordeauxâCHU Bordeaux, Bordeaux, France
type:PostalAddress
type:Organization
type:Person
name:Denis Maillet
affiliation:
name:Hospital Lyon Sud
address:
name:Department of Medical Oncology, Hospital Lyon Sud, Lyon, France
type:PostalAddress
type:Organization
type:Person
name:Maria Jose Mendez
url:http://orcid.org/0000-0002-7460-1859
affiliation:
name:Reina Sofia University Hospital
address:
name:Department of Medical Oncology, Reina Sofia University Hospital, Cordoba, Spain
type:PostalAddress
type:Organization
type:Person
name:Cristina Suarez
affiliation:
name:Vall dâHebron University Hospital, Universitat Autonoma de Barcelona
address:
name:Vall dâHebron Institute of Oncology, Vall dâHebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain
type:PostalAddress
type:Organization
type:Person
name:Mark Linch
affiliation:
name:University College London Hospital
address:
name:Department of Medical Oncology, University College London Hospital, London, UK
type:PostalAddress
type:Organization
type:Person
name:Aaron Prendergast
url:http://orcid.org/0000-0002-9668-6689
affiliation:
name:Queen Mary University of London
address:
name:Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK
type:PostalAddress
type:Organization
type:Person
name:Pieter-Jan van Dam
url:http://orcid.org/0000-0001-9074-8271
affiliation:
name:HistogeneX N.V.
address:
name:HistogeneX N.V., Wilrijk, Belgium
type:PostalAddress
type:Organization
type:Person
name:Diana Stanoeva
affiliation:
name:HistogeneX N.V.
address:
name:HistogeneX N.V., Wilrijk, Belgium
type:PostalAddress
type:Organization
type:Person
name:Sofie Daelemans
affiliation:
name:HistogeneX N.V.
address:
name:HistogeneX N.V., Wilrijk, Belgium
type:PostalAddress
type:Organization
name:University of Antwerp
address:
name:Medical Biochemistry, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium
type:PostalAddress
type:Organization
type:Person
name:Sanjeev Mariathasan
affiliation:
name:Genentech
address:
name:Genentech, San Francisco, USA
type:PostalAddress
type:Organization
type:Person
name:Joy S. Tea
url:http://orcid.org/0000-0002-3395-149X
affiliation:
name:Genentech
address:
name:Genentech, San Francisco, USA
type:PostalAddress
type:Organization
type:Person
name:Kelly Mousa
affiliation:
name:Queen Mary University of London
address:
name:Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK
type:PostalAddress
type:Organization
type:Person
name:Romain Banchereau
affiliation:
name:Genentech
address:
name:Genentech, San Francisco, USA
type:PostalAddress
type:Organization
type:Person
name:Daniel Castellano
affiliation:
name:Hospital 12 de Octubre
address:
name:Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
description:Antibodies targeting PD-1 or its ligand 1 PD-L1 such as atezolizumab, have great efficacy in a proportion of metastatic urothelial cancers1,2. Biomarkers may facilitate identification of these responding tumors3. Neoadjuvant use of these agents is associated with pathological complete response in a spectrum of tumors, including urothelial cancer4â7. Sequential tissue sampling from these studies allowed for detailed on-treatment biomarker analysis. Here, we present a single-arm phase 2 study, investigating two cycles of atezolizumab before cystectomy in 95 patients with muscle-invasive urothelial cancer (ClinicalTrials.gov identifier:
NCT02662309
). Pathological complete response was the primary endpoint. Secondary endpoints focused on safety, relapse-free survival and biomarker analysis. The pathological complete response rate was 31% (95% confidence interval: 21â41%), achieving the primary efficacy endpoint. Baseline biomarkers showed that the presence of preexisting activated T cells was more prominent than expected and correlated with outcome. Other established biomarkers, such as tumor mutational burden, did not predict outcome, differentiating this from the metastatic setting. Dynamic changes to gene expression signatures and protein biomarkers occurred with therapy, whereas changes in DNA alterations with treatment were uncommon. Responding tumors showed predominant expression of genes related to tissue repair after treatment, making tumor biomarker interpretation challenging in this group. Stromal factors such as transforming growth factor-β and fibroblast activation protein were linked to resistance, as was high expression of cell cycle gene signatures after treatment. A single-arm multicenter phase 2 trial demonstrates clinical efficacy of neoadjuvant PD-L1 blockade in patients with resectable muscle-invasive bladder cancer ineligible for cisplatin and examines biomarkers associated with patient outcome.
datePublished:2019-11-04T00:00:00Z
dateModified:2023-03-21T00:00:00Z
pageStart:1706
pageEnd:1714
sameAs:https://doi.org/10.1038/s41591-019-0628-7
keywords:
Bladder cancer
Predictive markers
Biomedicine
general
Cancer Research
Metabolic Diseases
Infectious Diseases
Molecular Medicine
Neurosciences
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-019-0628-7/MediaObjects/41591_2019_628_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-019-0628-7/MediaObjects/41591_2019_628_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-019-0628-7/MediaObjects/41591_2019_628_Fig3_HTML.png
isPartOf:
name:Nature Medicine
issn:
1546-170X
1078-8956
volumeNumber:25
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Thomas Powles
url:http://orcid.org/0000-0001-7760-4724
affiliation:
name:Queen Mary University of London
address:
name:Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Mark Kockx
affiliation:
name:HistogeneX N.V.
address:
name:HistogeneX N.V., Wilrijk, Belgium
type:PostalAddress
type:Organization
type:Person
name:Alejo Rodriguez-Vida
affiliation:
name:Hospital del Mar
address:
name:Department of Medical Oncology, Hospital del Mar, Barcelona, Spain
type:PostalAddress
type:Organization
type:Person
name:Ignacio Duran
affiliation:
name:IBiS, Hospital Universitario Virgen del Rocio, CSIC and Universidad de Sevilla
address:
name:Instituto de Biomedicina de Sevilla, IBiS, Hospital Universitario Virgen del Rocio, CSIC and Universidad de Sevilla, Seville, Spain
type:PostalAddress
type:Organization
type:Person
name:Simon J. Crabb
url:http://orcid.org/0000-0003-3521-9064
affiliation:
name:University of Southampton
address:
name:Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK
type:PostalAddress
type:Organization
type:Person
name:Michiel S. Van Der Heijden
affiliation:
name:The Netherlands Cancer Institute
address:
name:Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands
type:PostalAddress
type:Organization
type:Person
name:Bernadett Szabados
affiliation:
name:Queen Mary University of London
address:
name:Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK
type:PostalAddress
type:Organization
type:Person
name:Albert Font Pous
affiliation:
name:Hospital Universitari Germans Trias i Pujol
address:
name:Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B.ARGO)-IGTP, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
type:PostalAddress
type:Organization
type:Person
name:Gwenaelle Gravis
affiliation:
name:Institut Paoli-Calmettes
address:
name:Institut Paoli-Calmettes, Marseille, France
type:PostalAddress
type:Organization
type:Person
name:Urbano Anido Herranz
url:http://orcid.org/0000-0003-0376-5642
affiliation:
name:Hospital Clinico Universitario de Santiago
address:
name:Department of Medical Oncology, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain
type:PostalAddress
type:Organization
type:Person
name:Andrew Protheroe
url:http://orcid.org/0000-0001-9413-0575
affiliation:
name:Churchill Hospital
address:
name:Department of Medical Oncology, Churchill Hospital, Oxford, UK
type:PostalAddress
type:Organization
type:Person
name:Alain Ravaud
affiliation:
name:University of BordeauxâCHU Bordeaux
address:
name:Department of Medical Oncology, Hopital Saint-Andre, University of BordeauxâCHU Bordeaux, Bordeaux, France
type:PostalAddress
type:Organization
type:Person
name:Denis Maillet
affiliation:
name:Hospital Lyon Sud
address:
name:Department of Medical Oncology, Hospital Lyon Sud, Lyon, France
type:PostalAddress
type:Organization
type:Person
name:Maria Jose Mendez
url:http://orcid.org/0000-0002-7460-1859
affiliation:
name:Reina Sofia University Hospital
address:
name:Department of Medical Oncology, Reina Sofia University Hospital, Cordoba, Spain
type:PostalAddress
type:Organization
type:Person
name:Cristina Suarez
affiliation:
name:Vall dâHebron University Hospital, Universitat Autonoma de Barcelona
address:
name:Vall dâHebron Institute of Oncology, Vall dâHebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain
type:PostalAddress
type:Organization
type:Person
name:Mark Linch
affiliation:
name:University College London Hospital
address:
name:Department of Medical Oncology, University College London Hospital, London, UK
type:PostalAddress
type:Organization
type:Person
name:Aaron Prendergast
url:http://orcid.org/0000-0002-9668-6689
affiliation:
name:Queen Mary University of London
address:
name:Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK
type:PostalAddress
type:Organization
type:Person
name:Pieter-Jan van Dam
url:http://orcid.org/0000-0001-9074-8271
affiliation:
name:HistogeneX N.V.
address:
name:HistogeneX N.V., Wilrijk, Belgium
type:PostalAddress
type:Organization
type:Person
name:Diana Stanoeva
affiliation:
name:HistogeneX N.V.
address:
name:HistogeneX N.V., Wilrijk, Belgium
type:PostalAddress
type:Organization
type:Person
name:Sofie Daelemans
affiliation:
name:HistogeneX N.V.
address:
name:HistogeneX N.V., Wilrijk, Belgium
type:PostalAddress
type:Organization
name:University of Antwerp
address:
name:Medical Biochemistry, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium
type:PostalAddress
type:Organization
type:Person
name:Sanjeev Mariathasan
affiliation:
name:Genentech
address:
name:Genentech, San Francisco, USA
type:PostalAddress
type:Organization
type:Person
name:Joy S. Tea
url:http://orcid.org/0000-0002-3395-149X
affiliation:
name:Genentech
address:
name:Genentech, San Francisco, USA
type:PostalAddress
type:Organization
type:Person
name:Kelly Mousa
affiliation:
name:Queen Mary University of London
address:
name:Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK
type:PostalAddress
type:Organization
type:Person
name:Romain Banchereau
affiliation:
name:Genentech
address:
name:Genentech, San Francisco, USA
type:PostalAddress
type:Organization
type:Person
name:Daniel Castellano
affiliation:
name:Hospital 12 de Octubre
address:
name:Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Nature Medicine
issn:
1546-170X
1078-8956
volumeNumber:25
Organization:
name:Nature Publishing Group US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Queen Mary University of London
address:
name:Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK
type:PostalAddress
name:HistogeneX N.V.
address:
name:HistogeneX N.V., Wilrijk, Belgium
type:PostalAddress
name:Hospital del Mar
address:
name:Department of Medical Oncology, Hospital del Mar, Barcelona, Spain
type:PostalAddress
name:IBiS, Hospital Universitario Virgen del Rocio, CSIC and Universidad de Sevilla
address:
name:Instituto de Biomedicina de Sevilla, IBiS, Hospital Universitario Virgen del Rocio, CSIC and Universidad de Sevilla, Seville, Spain
type:PostalAddress
name:University of Southampton
address:
name:Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK
type:PostalAddress
name:The Netherlands Cancer Institute
address:
name:Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands
type:PostalAddress
name:Queen Mary University of London
address:
name:Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK
type:PostalAddress
name:Hospital Universitari Germans Trias i Pujol
address:
name:Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B.ARGO)-IGTP, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
type:PostalAddress
name:Institut Paoli-Calmettes
address:
name:Institut Paoli-Calmettes, Marseille, France
type:PostalAddress
name:Hospital Clinico Universitario de Santiago
address:
name:Department of Medical Oncology, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain
type:PostalAddress
name:Churchill Hospital
address:
name:Department of Medical Oncology, Churchill Hospital, Oxford, UK
type:PostalAddress
name:University of BordeauxâCHU Bordeaux
address:
name:Department of Medical Oncology, Hopital Saint-Andre, University of BordeauxâCHU Bordeaux, Bordeaux, France
type:PostalAddress
name:Hospital Lyon Sud
address:
name:Department of Medical Oncology, Hospital Lyon Sud, Lyon, France
type:PostalAddress
name:Reina Sofia University Hospital
address:
name:Department of Medical Oncology, Reina Sofia University Hospital, Cordoba, Spain
type:PostalAddress
name:Vall dâHebron University Hospital, Universitat Autonoma de Barcelona
address:
name:Vall dâHebron Institute of Oncology, Vall dâHebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain
type:PostalAddress
name:University College London Hospital
address:
name:Department of Medical Oncology, University College London Hospital, London, UK
type:PostalAddress
name:Queen Mary University of London
address:
name:Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK
type:PostalAddress
name:HistogeneX N.V.
address:
name:HistogeneX N.V., Wilrijk, Belgium
type:PostalAddress
name:HistogeneX N.V.
address:
name:HistogeneX N.V., Wilrijk, Belgium
type:PostalAddress
name:HistogeneX N.V.
address:
name:HistogeneX N.V., Wilrijk, Belgium
type:PostalAddress
name:University of Antwerp
address:
name:Medical Biochemistry, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium
type:PostalAddress
name:Genentech
address:
name:Genentech, San Francisco, USA
type:PostalAddress
name:Genentech
address:
name:Genentech, San Francisco, USA
type:PostalAddress
name:Queen Mary University of London
address:
name:Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK
type:PostalAddress
name:Genentech
address:
name:Genentech, San Francisco, USA
type:PostalAddress
name:Hospital 12 de Octubre
address:
name:Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Thomas Powles
url:http://orcid.org/0000-0001-7760-4724
affiliation:
name:Queen Mary University of London
address:
name:Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK
type:PostalAddress
type:Organization
email:[email protected]
name:Mark Kockx
affiliation:
name:HistogeneX N.V.
address:
name:HistogeneX N.V., Wilrijk, Belgium
type:PostalAddress
type:Organization
name:Alejo Rodriguez-Vida
affiliation:
name:Hospital del Mar
address:
name:Department of Medical Oncology, Hospital del Mar, Barcelona, Spain
type:PostalAddress
type:Organization
name:Ignacio Duran
affiliation:
name:IBiS, Hospital Universitario Virgen del Rocio, CSIC and Universidad de Sevilla
address:
name:Instituto de Biomedicina de Sevilla, IBiS, Hospital Universitario Virgen del Rocio, CSIC and Universidad de Sevilla, Seville, Spain
type:PostalAddress
type:Organization
name:Simon J. Crabb
url:http://orcid.org/0000-0003-3521-9064
affiliation:
name:University of Southampton
address:
name:Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK
type:PostalAddress
type:Organization
name:Michiel S. Van Der Heijden
affiliation:
name:The Netherlands Cancer Institute
address:
name:Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands
type:PostalAddress
type:Organization
name:Bernadett Szabados
affiliation:
name:Queen Mary University of London
address:
name:Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK
type:PostalAddress
type:Organization
name:Albert Font Pous
affiliation:
name:Hospital Universitari Germans Trias i Pujol
address:
name:Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B.ARGO)-IGTP, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
type:PostalAddress
type:Organization
name:Gwenaelle Gravis
affiliation:
name:Institut Paoli-Calmettes
address:
name:Institut Paoli-Calmettes, Marseille, France
type:PostalAddress
type:Organization
name:Urbano Anido Herranz
url:http://orcid.org/0000-0003-0376-5642
affiliation:
name:Hospital Clinico Universitario de Santiago
address:
name:Department of Medical Oncology, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain
type:PostalAddress
type:Organization
name:Andrew Protheroe
url:http://orcid.org/0000-0001-9413-0575
affiliation:
name:Churchill Hospital
address:
name:Department of Medical Oncology, Churchill Hospital, Oxford, UK
type:PostalAddress
type:Organization
name:Alain Ravaud
affiliation:
name:University of BordeauxâCHU Bordeaux
address:
name:Department of Medical Oncology, Hopital Saint-Andre, University of BordeauxâCHU Bordeaux, Bordeaux, France
type:PostalAddress
type:Organization
name:Denis Maillet
affiliation:
name:Hospital Lyon Sud
address:
name:Department of Medical Oncology, Hospital Lyon Sud, Lyon, France
type:PostalAddress
type:Organization
name:Maria Jose Mendez
url:http://orcid.org/0000-0002-7460-1859
affiliation:
name:Reina Sofia University Hospital
address:
name:Department of Medical Oncology, Reina Sofia University Hospital, Cordoba, Spain
type:PostalAddress
type:Organization
name:Cristina Suarez
affiliation:
name:Vall dâHebron University Hospital, Universitat Autonoma de Barcelona
address:
name:Vall dâHebron Institute of Oncology, Vall dâHebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain
type:PostalAddress
type:Organization
name:Mark Linch
affiliation:
name:University College London Hospital
address:
name:Department of Medical Oncology, University College London Hospital, London, UK
type:PostalAddress
type:Organization
name:Aaron Prendergast
url:http://orcid.org/0000-0002-9668-6689
affiliation:
name:Queen Mary University of London
address:
name:Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK
type:PostalAddress
type:Organization
name:Pieter-Jan van Dam
url:http://orcid.org/0000-0001-9074-8271
affiliation:
name:HistogeneX N.V.
address:
name:HistogeneX N.V., Wilrijk, Belgium
type:PostalAddress
type:Organization
name:Diana Stanoeva
affiliation:
name:HistogeneX N.V.
address:
name:HistogeneX N.V., Wilrijk, Belgium
type:PostalAddress
type:Organization
name:Sofie Daelemans
affiliation:
name:HistogeneX N.V.
address:
name:HistogeneX N.V., Wilrijk, Belgium
type:PostalAddress
type:Organization
name:University of Antwerp
address:
name:Medical Biochemistry, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium
type:PostalAddress
type:Organization
name:Sanjeev Mariathasan
affiliation:
name:Genentech
address:
name:Genentech, San Francisco, USA
type:PostalAddress
type:Organization
name:Joy S. Tea
url:http://orcid.org/0000-0002-3395-149X
affiliation:
name:Genentech
address:
name:Genentech, San Francisco, USA
type:PostalAddress
type:Organization
name:Kelly Mousa
affiliation:
name:Queen Mary University of London
address:
name:Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK
type:PostalAddress
type:Organization
name:Romain Banchereau
affiliation:
name:Genentech
address:
name:Genentech, San Francisco, USA
type:PostalAddress
type:Organization
name:Daniel Castellano
affiliation:
name:Hospital 12 de Octubre
address:
name:Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain
type:PostalAddress
type:Organization
PostalAddress:
name:Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK
name:HistogeneX N.V., Wilrijk, Belgium
name:Department of Medical Oncology, Hospital del Mar, Barcelona, Spain
name:Instituto de Biomedicina de Sevilla, IBiS, Hospital Universitario Virgen del Rocio, CSIC and Universidad de Sevilla, Seville, Spain
name:Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK
name:Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands
name:Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK
name:Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B.ARGO)-IGTP, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
name:Institut Paoli-Calmettes, Marseille, France
name:Department of Medical Oncology, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain
name:Department of Medical Oncology, Churchill Hospital, Oxford, UK
name:Department of Medical Oncology, Hopital Saint-Andre, University of BordeauxâCHU Bordeaux, Bordeaux, France
name:Department of Medical Oncology, Hospital Lyon Sud, Lyon, France
name:Department of Medical Oncology, Reina Sofia University Hospital, Cordoba, Spain
name:Vall dâHebron Institute of Oncology, Vall dâHebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain
name:Department of Medical Oncology, University College London Hospital, London, UK
name:Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK
name:HistogeneX N.V., Wilrijk, Belgium
name:HistogeneX N.V., Wilrijk, Belgium
name:HistogeneX N.V., Wilrijk, Belgium
name:Medical Biochemistry, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium
name:Genentech, San Francisco, USA
name:Genentech, San Francisco, USA
name:Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK
name:Genentech, San Francisco, USA
name:Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
Social Networks {👍}(2)
External Links {🔗}(289)
- How much profit does https://www.nature.com/info/privacy make?
- Explore the financials of https://www.nature.com/articles/s41591-019-0628-7/#content
- What's the total monthly financial gain of https://www.nature.com/articles/s41591-019-0628-7/nm?
- What's the income of https://www.nature.com/siteindex?
- Learn how profitable https://www.nature.com/articles/s41591-019-0628-7/javascript:; is on a monthly basis
- How much does https://www.nature.com/articles/s41591-019-0628-7/search/advanced bring in each month?
- Discover the revenue of https://www.nature.com/articles/s41591-019-0628-7/subjects
- How much does https://www.nature.com/articles/s41591-019-0628-7/naturecareers earn?
- https://www.nature.com/articles/s41591-019-0628-7/authors/index.html income
- Learn how profitable https://www.nature.com/articles/s41591-019-0628-7/authors/editorial_policies/ is on a monthly basis
- Learn about the earnings of https://idp.nature.com/auth/personal/springernature?redirect_uri=https://www.nature.com/articles/s41591-019-0628-7
- How much profit is https://www.nature.com/articles/s41591-019-0628-7/nm/research-articles making per month?
- How much profit does https://www.nature.com/articles/s41591-019-0628-7/nm/reviews-and-analysis generate?
- How much does https://www.nature.com/articles/s41591-019-0628-7/nm/news-and-comment earn?
- What's the income of https://www.nature.com/articles/s41591-019-0628-7/nm/podcast?
- How profitable is https://www.nature.com/articles/s41591-019-0628-7/nm/current-issue?
- How much does https://www.nature.com/articles/s41591-019-0628-7/nm/collections bring in each month?
- See how much https://www.nature.com/nm/subscribe makes per month
- How much does https://www.nature.com/my-account/alerts/subscribe-journal?list-id=5 rake in every month?
- What's the monthly income of https://www.nature.com/nm.rss?
- Check the income stats for https://www.nature.com/articles/s41591-019-0628-7/nm/aims
- What are the total earnings of https://www.nature.com/articles/s41591-019-0628-7/nm/journal-information?
- How much does https://www.nature.com/articles/s41591-019-0628-7/nm/journal-impact rake in every month?
- Explore the financials of https://www.nature.com/articles/s41591-019-0628-7/nm/editors
- Get to know https://www.nature.com/articles/s41591-019-0628-7/nm/research-cross-journal-editorial-team's earnings
- https://www.nature.com/articles/s41591-019-0628-7/nm/reviews-cross-journal-editorial-team's financial summary
- How much money does https://www.nature.com/articles/s41591-019-0628-7/nm/statistics-advisory-panel generate?
- How much money does https://www.nature.com/articles/s41591-019-0628-7/nm/our-publishing-models generate?
- What's the monthly money flow for https://www.nature.com/articles/s41591-019-0628-7/nm/editorial-values-statement?
- How much revenue does https://www.nature.com/articles/s41591-019-0628-7/nm/editorial-policies generate?
- https://www.nature.com/articles/s41591-019-0628-7/nm/content's total income per month
- How much does https://www.nature.com/articles/s41591-019-0628-7/nm/web-feeds bring in each month?
- How much money does https://www.nature.com/articles/s41591-019-0628-7/nm/contact make?
- https://www.nature.com/articles/s41591-019-0628-7/nm/submission-guidelines income
- How much does https://www.nature.com/articles/s41591-019-0628-7/nm/for-reviewers gross monthly?
- How much does https://authorservices.springernature.com/go/sn/?utm_source=For+Authors&utm_medium=Website_Nature&utm_campaign=Platform+Experimentation+2022&utm_id=PE2022 pull in?
- Learn about the earnings of https://www.nature.com/articles/s41591-019-0628-7/nm/open-access-funding
- Get to know what's the income of https://mts-nmed.nature.com/cgi-bin/main.plex
- How much does https://www.nature.com/articles/s41591-019-0628-7/nm/subscribe net monthly?
- What are the total earnings of https://journal-alerts.springernature.com/subscribe?journal_id=41591?
- Find out how much https://www.nature.com/articles/s41591-019-0628-7/ earns monthly
- How much does https://www.nature.com/articles/s41591-019-0628-7/nm/articles?type=letter net monthly?
- How much revenue does https://www.nature.com/articles/s41591-019-0628-7/#auth-Thomas-Powles-Aff1 produce monthly?
- What is the monthly revenue of https://orcid.org/0000-0001-7760-4724?
- How much does https://www.nature.com/articles/s41591-019-0628-7/#Aff1 generate monthly?
- Profit of https://www.nature.com/articles/s41591-019-0628-7/#auth-Mark-Kockx-Aff2
- What is the monthly revenue of https://www.nature.com/articles/s41591-019-0628-7/#Aff2?
- How much profit is https://www.nature.com/articles/s41591-019-0628-7/#auth-Alejo-Rodriguez_Vida-Aff3 making per month?
- What's the income of https://www.nature.com/articles/s41591-019-0628-7/#Aff3?
- https://www.nature.com/articles/s41591-019-0628-7/#auth-Ignacio-Duran-Aff4's financial summary
- How much does https://www.nature.com/articles/s41591-019-0628-7/#Aff4 pull in monthly?
- https://www.nature.com/articles/s41591-019-0628-7/#auth-Simon_J_-Crabb-Aff5's revenue stream
- Earnings of https://orcid.org/0000-0003-3521-9064
- Financial intake of https://www.nature.com/articles/s41591-019-0628-7/#Aff5
- What's the profit of https://www.nature.com/articles/s41591-019-0628-7/#auth-Michiel_S_-Heijden-Aff6?
- How much does https://www.nature.com/articles/s41591-019-0628-7/#Aff6 gross monthly?
- See how much https://www.nature.com/articles/s41591-019-0628-7/#auth-Bernadett-Szabados-Aff1 makes per month
- What's the monthly money flow for https://www.nature.com/articles/s41591-019-0628-7/#auth-Albert_Font-Pous-Aff7?
- What's the financial intake of https://www.nature.com/articles/s41591-019-0628-7/#Aff7?
- Monthly income for https://www.nature.com/articles/s41591-019-0628-7/#auth-Gwenaelle-Gravis-Aff8
- What's the financial outcome of https://www.nature.com/articles/s41591-019-0628-7/#Aff8?
- How much does https://www.nature.com/articles/s41591-019-0628-7/#auth-Urbano_Anido-Herranz-Aff9 pull in monthly?
- How much income does https://orcid.org/0000-0003-0376-5642 have?
- What's the monthly money flow for https://www.nature.com/articles/s41591-019-0628-7/#Aff9?
- What's the monthly money flow for https://www.nature.com/articles/s41591-019-0628-7/#auth-Andrew-Protheroe-Aff10?
- How much profit does https://orcid.org/0000-0001-9413-0575 make?
- Revenue of https://www.nature.com/articles/s41591-019-0628-7/#Aff10
- What is the earnings of https://www.nature.com/articles/s41591-019-0628-7/#auth-Alain-Ravaud-Aff11?
- How much does https://www.nature.com/articles/s41591-019-0628-7/#Aff11 bring in each month?
- What's the profit of https://www.nature.com/articles/s41591-019-0628-7/#auth-Denis-Maillet-Aff12?
- What are the total earnings of https://www.nature.com/articles/s41591-019-0628-7/#Aff12?
- https://www.nature.com/articles/s41591-019-0628-7/#auth-Maria_Jose-Mendez-Aff13 income
- What's the monthly income of https://orcid.org/0000-0002-7460-1859?
- How much revenue does https://www.nature.com/articles/s41591-019-0628-7/#Aff13 produce monthly?
- How much does https://www.nature.com/articles/s41591-019-0628-7/#auth-Cristina-Suarez-Aff14 gross monthly?
- What are the total earnings of https://www.nature.com/articles/s41591-019-0628-7/#Aff14?
- How much profit does https://www.nature.com/articles/s41591-019-0628-7/#auth-Mark-Linch-Aff15 make?
- Learn how profitable https://www.nature.com/articles/s41591-019-0628-7/#Aff15 is on a monthly basis
- What's the total monthly financial gain of https://www.nature.com/articles/s41591-019-0628-7/#auth-Aaron-Prendergast-Aff1?
- What is the earnings of https://orcid.org/0000-0002-9668-6689?
- What's the monthly money flow for https://www.nature.com/articles/s41591-019-0628-7/#auth-Pieter_Jan-Dam-Aff2?
- How much revenue does https://orcid.org/0000-0001-9074-8271 generate?
- How much does https://www.nature.com/articles/s41591-019-0628-7/#auth-Diana-Stanoeva-Aff2 gross monthly?
- How much does https://www.nature.com/articles/s41591-019-0628-7/#auth-Sofie-Daelemans-Aff2-Aff16 make?
- How much cash flow does https://www.nature.com/articles/s41591-019-0628-7/#Aff16 have monthly?
- What's the profit of https://www.nature.com/articles/s41591-019-0628-7/#auth-Sanjeev-Mariathasan-Aff17?
- Revenue of https://www.nature.com/articles/s41591-019-0628-7/#Aff17
- Explore the financials of https://www.nature.com/articles/s41591-019-0628-7/#auth-Joy_S_-Tea-Aff17
- How much money does https://orcid.org/0000-0002-3395-149X make?
- What's https://www.nature.com/articles/s41591-019-0628-7/#auth-Kelly-Mousa-Aff1's gross income?
- How much does https://www.nature.com/articles/s41591-019-0628-7/#auth-Romain-Banchereau-Aff17 pull in monthly?
- What's the revenue for https://www.nature.com/articles/s41591-019-0628-7/#na1?
- How much does https://www.nature.com/articles/s41591-019-0628-7/#auth-Daniel-Castellano-Aff18 make?
- How much income is https://www.nature.com/articles/s41591-019-0628-7/#Aff18 earning monthly?
- How much money does https://www.nature.com/articles/s41591-019-0628-7/#citeas generate?
- How much does https://www.nature.com/articles/s41591-019-0628-7/articles/s41591-019-0628-7/metrics make?
- How much does https://www.nature.com/articles/s41591-019-0628-7/#change-history rake in every month?
- How much profit does https://www.nature.com/articles/s41591-019-0628-7/articles/s41591-019-0628-7#ref-CR1 generate?
- How much does https://www.nature.com/articles/s41591-019-0628-7/articles/s41591-019-0628-7#ref-CR2 gross monthly?
- Check the income stats for https://www.nature.com/articles/s41591-019-0628-7/articles/s41591-019-0628-7#ref-CR3
- How much profit does https://www.nature.com/articles/s41591-019-0628-7/#ref-CR4 generate?
- How much does https://www.nature.com/articles/s41591-019-0628-7/#ref-CR5 pull in monthly?
- What's the income generated by https://www.nature.com/articles/s41591-019-0628-7/#ref-CR6 each month?
- How much does https://www.nature.com/articles/s41591-019-0628-7/articles/s41591-019-0628-7#ref-CR7 rake in every month?
- How much income is https://clinicaltrials.gov/ct2/show/NCT02662309?term=NCT02662309&rank=1 earning monthly?
- What's the revenue for https://wayf.springernature.com?redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41591-019-0628-7?
- How much revenue does https://www.nature.com/articles/s41591-019-0628-7/#access-options generate?
- https://shop-amers.nature.com/products/plus/?region=US's financial summary
- How much does https://link.springer.com/article/10.1038/s41591-019-0628-7?utm_source=nature&utm_medium=referral&utm_campaign=buyArticle pull in?
- Discover the revenue of https://idp.nature.com/authorize/natureuser?client_id=grover&redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41591-019-0628-7
- How much does https://www.springernature.com/gp/librarians/licensing/license-options make?
- See how much https://support.nature.com/en/support/home makes per month
- Get to know https://www.springernature.com/gp/contact's earnings
- What's the profit of https://www.nature.com/articles/s41586-021-03642-9?fromPaywallRec=true?
- How much does https://www.nature.com/articles/s41401-023-01079-6?fromPaywallRec=true gross monthly?
- How much income is https://www.nature.com/articles/s41698-025-00969-8?fromPaywallRec=true earning monthly?
- Learn about the earnings of https://www.nature.com/articles/s41591-019-0628-7/articles/cas-redirect/1:CAS:528:DC%2BC2sXit1eqsrk%3D
- Financial intake of http://scholar.google.com/scholar_lookup?&title=A%20review%20on%20the%20evolution%20of%20PD-1%2FPD-L1%20immunotherapy%20for%20bladder%20cancer%3A%20the%20future%20is%20now&journal=Cancer%20Treat.%20Rev.&doi=10.1016%2Fj.ctrv.2017.01.007&volume=54&pages=58-67&publication_year=2017&author=Bellmunt%2CJ&author=Powles%2CT&author=Vogelzang%2CNJ
- https://www.nature.com/articles/s41591-019-0628-7/articles/cas-redirect/1:CAS:528:DC%2BC2sXitVWmu77L income
- How much does http://scholar.google.com/scholar_lookup?&title=Atezolizumab%20versus%20chemotherapy%20in%20patients%20with%20platinum-treated%20locally%20advanced%20or%20metastatic%20urothelial%20carcinoma%20%28IMvigor211%29%3A%20a%20multicentre%2C%20open-label%2C%20phase%203%20randomised%20controlled%20trial&journal=Lancet&doi=10.1016%2FS0140-6736%2817%2933297-X&volume=391&pages=748-757&publication_year=2018&author=Powles%2CT pull in?
- Learn how profitable https://www.nature.com/articles/s41591-019-0628-7/articles/cas-redirect/1:CAS:528:DC%2BC1cXisl2ls7c%3D is on a monthly basis
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=TGF-%CE%B2%20attenuates%20tumour%20response%20to%20PD-L1%20blockade%20by%20contributing%20to%20exclusion%20of%20T%20cells&journal=Nature&doi=10.1038%2Fnature25501&volume=554&pages=544-548&publication_year=2018&author=Mariathasan%2CS is on a monthly basis
- Discover the revenue of https://www.nature.com/articles/s41591-019-0628-7/articles/cas-redirect/1:CAS:528:DC%2BC1cXitVCit7rM
- What's http://scholar.google.com/scholar_lookup?&title=Neoadjuvant%20versus%20adjuvant%20ipilimumab%20plus%20nivolumab%20in%20macroscopic%20stage%20III%20melanoma&journal=Nat.%20Med.&doi=10.1038%2Fs41591-018-0198-0&volume=24&pages=1655-1661&publication_year=2018&author=Blank%2CCU's gross income?
- How much revenue does https://www.nature.com/articles/s41591-019-0628-7/articles/cas-redirect/1:CAS:528:DC%2BC1MXhtVKlsbnP bring in?
- http://scholar.google.com/scholar_lookup?&title=Pembrolizumab%20as%20neoadjuvant%20therapy%20before%20radical%20cystectomy%20in%20patients%20with%20muscle-invasive%20urothelial%20bladder%20carcinoma%20%28PURE-01%29%3A%20an%20open-label%2C%20single-arm%2C%20phase%20II%20study&journal=J.%20Clin.%20Oncol.&doi=10.1200%2FJCO.18.01148&volume=36&pages=3353-3360&publication_year=2018&author=Necchi%2CA income
- How much income does https://www.nature.com/articles/s41591-019-0628-7/articles/cas-redirect/1:CAS:528:DC%2BC1MXmsVymtL8%3D have?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Neoadjuvant%20anti-PD-1%20immunotherapy%20promotes%20a%20survival%20benefit%20with%20intratumoral%20and%20systemic%20immune%20responses%20in%20recurrent%20glioblastoma&journal=Nat.%20Med.&doi=10.1038%2Fs41591-018-0337-7&volume=25&pages=477-486&publication_year=2019&author=Cloughesy%2CTF bring in?
- What's the financial outcome of https://www.nature.com/articles/s41591-019-0628-7/articles/cas-redirect/1:CAS:528:DC%2BC1cXitVWjtLjL?
- How much does http://scholar.google.com/scholar_lookup?&title=Neoadjuvant%20immune%20checkpoint%20blockade%20in%20high-risk%20resectable%20melanoma&journal=Nat.%20Med.&doi=10.1038%2Fs41591-018-0197-1&volume=24&pages=1649-1654&publication_year=2018&author=Amaria%2CRN net monthly?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Trends%20in%20the%20use%20of%20perioperative%20chemotherapy%20for%20localized%20and%20locally%20advanced%20muscle-invasive%20bladder%20cancer%3A%20a%20sign%20of%20changing%20tides&journal=Eur.%20Urol.&doi=10.1016%2Fj.eururo.2014.01.009&volume=67&pages=165-170&publication_year=2015&author=Reardon%2CZD
- http://scholar.google.com/scholar_lookup?&title=International%20phase%20III%20trial%20assessing%20neoadjuvant%20cisplatin%2C%20methotrexate%2C%20and%20vinblastine%20chemotherapy%20for%20muscle-invasive%20bladder%20cancer%3A%20long-term%20results%20of%20the%20BA06%2030894%20trial&journal=J.%20Clin.%20Oncol.&doi=10.1200%2FJCO.2010.32.3139&volume=29&pages=2171-2177&publication_year=2011's financial summary
- What's the financial intake of https://www.nature.com/articles/s41591-019-0628-7/articles/cas-redirect/1:CAS:528:DC%2BC28XktVyktbw%3D?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Pathological%20T0%20following%20cisplatin-based%20neoadjuvant%20chemotherapy%20for%20muscle-invasive%20bladder%20cancer%3A%20a%20network%20meta-analysis&journal=Clin.%20Cancer%20Res.&doi=10.1158%2F1078-0432.CCR-15-1208&volume=22&pages=1086-1094&publication_year=2016&author=Kim%2CHS&author=Jeong%2CCW&author=Kwak%2CC&author=Kim%2CHH&author=Ku%2CJH earns monthly
- How much revenue does https://www.nature.com/articles/s41591-019-0628-7/articles/cas-redirect/1:CAS:528:DC%2BC1cXhtVGmt7bL generate?
- How much income does http://scholar.google.com/scholar_lookup?&title=Neoadjuvant%20PD-1%20blockade%20in%20resectable%20lung%20cancer&journal=N.%20Engl.%20J.%20Med.&doi=10.1056%2FNEJMoa1716078&volume=378&pages=1976-1986&publication_year=2018&author=Forde%2CPM have?
- Discover the revenue of https://www.nature.com/articles/s41591-019-0628-7/articles/cas-redirect/1:CAS:528:DC%2BC1MXmsVyruro%3D
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=A%20single%20dose%20of%20neoadjuvant%20PD-1%20blockade%20predicts%20clinical%20outcomes%20in%20resectable%20melanoma&journal=Nat.%20Med.&doi=10.1038%2Fs41591-019-0357-y&volume=25&pages=454-461&publication_year=2019&author=Huang%2CAC
- See how much https://www.nature.com/articles/s41591-019-0628-7/articles/cas-redirect/1:CAS:528:DC%2BC28XjslGmu7w%3D makes per month
- Profit of http://scholar.google.com/scholar_lookup?&title=Atezolizumab%20in%20patients%20with%20locally%20advanced%20and%20metastatic%20urothelial%20carcinoma%20who%20have%20progressed%20following%20treatment%20with%20platinum-based%20chemotherapy%3A%20a%20single-arm%2C%20multicentre%2C%20phase%202%20trial&journal=Lancet&doi=10.1016%2FS0140-6736%2816%2900561-4&volume=387&pages=1909-1920&publication_year=2016&author=Rosenberg%2CJE
- How much does https://www.nature.com/articles/s41591-019-0628-7/articles/cas-redirect/1:CAS:528:DC%2BD2sXhtFSnt77P rake in every month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Granzyme%20B%20production%20distinguishes%20recently%20activated%20CD8%2B%20memory%20cells%20from%20resting%20memory%20cells&journal=Cell%20Immunol&doi=10.1016%2Fj.cellimm.2007.07.004&volume=247&pages=36-48&publication_year=2007&author=Nowacki%2CTM generate?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Atezolizumab%20%28atezo%29%20vs.%20chemotherapy%20%28chemo%29%20in%20platinum-treated%20locally%20advanced%20or%20metastatic%20urothelial%20carcinoma%20%28mUC%29%3A%20immune%20biomarkers%2C%20tumor%20mutational%20burden%20%28TMB%29%2C%20and%20clinical%20outcomes%20from%20the%20phase%20III%20IMvigor211%20study&journal=J.%20Clin.%20Oncol.&doi=10.1200%2FJCO.2018.36.6_suppl.409&volume=36&pages=409-409&publication_year=2018&author=Powles%2CT
- How much money does https://www.nature.com/articles/s41591-019-0628-7/articles/cas-redirect/1:CAS:528:DC%2BC1MXhvV2iurs%3D make?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Alterations%20in%20DNA%20damage%20response%20and%20repair%20genes%20as%20potential%20marker%20of%20clinical%20benefit%20from%20PD-1%2FPD-L1%20blockade%20in%20advanced%20urothelial%20cancers&journal=J.%20Clin.%20Oncol.&doi=10.1200%2FJCO.2017.75.7740&volume=36&pages=1685-1694&publication_year=2018&author=Teo%2CMY bring in?
- How much income does https://www.nature.com/articles/s41591-019-0628-7/articles/cas-redirect/1:CAS:528:DC%2BC38XpvFGgtLc%3D have?
- http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20fibrosis%3A%20therapeutic%20translation%20for%20fibrotic%20disease&journal=Nat.%20Med.&doi=10.1038%2Fnm.2807&volume=18&pages=1028-1040&publication_year=2012&author=Wynn%2CTA&author=Ramalingam%2CTR's total income per month
- What's the total monthly financial gain of https://www.nature.com/articles/s41591-019-0628-7/articles/cas-redirect/1:CAS:528:DC%2BC28XhsFKjur%2FM?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Cancer-associated%20fibroblast%20exosomes%20regulate%20survival%20and%20proliferation%20of%20pancreatic%20cancer%20cells&journal=Oncogene&doi=10.1038%2Fonc.2016.353&volume=36&pages=1770-1778&publication_year=2017&author=Richards%2CKE generate?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=A%20molecular%20taxonomy%20for%20urothelial%20carcinoma&journal=Clin.%20Cancer%20Res.&doi=10.1158%2F1078-0432.CCR-12-0077-T&volume=18&pages=3377-3386&publication_year=2012&author=Sjodahl%2CG?
- How much profit does https://www.nature.com/articles/s41591-019-0628-7/articles/cas-redirect/1:CAS:528:DC%2BC1cXhslSksbbL make?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Intratumoral%20heterogeneity%20of%20bladder%20cancer%20by%20molecular%20subtypes%20and%20histologic%20variants&journal=Eur.%20Urol.&doi=10.1016%2Fj.eururo.2018.09.003&volume=75&pages=18-22&publication_year=2019&author=Warrick%2CJI?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=WEE1%20kinase%20inhibition%20reverses%20G2%2FM%20cell%20cycle%20checkpoint%20activation%20to%20sensitize%20cancer%20cells%20to%20immunotherapy&journal=Oncoimmunology&doi=10.1080%2F2162402X.2018.1488359&volume=7&publication_year=2018&author=Sun%2CL?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Multicenter%20phase%20I%20study%20of%20erdafitinib%20%28JNJ-42756493%29%2C%20oral%20pan-fibroblast%20growth%20factor%20receptor%20inhibitor%2C%20in%20patients%20with%20advanced%20or%20refractory%20solid%20tumors&journal=Clin.%20Cancer%20Res.&doi=10.1158%2F1078-0432.CCR-18-3334&volume=25&pages=4888-4897&publication_year=2019&author=Bahleda%2CR
- What's http://scholar.google.com/scholar_lookup?&title=Mutational%20analysis%20of%20472%20urothelial%20carcinoma%20across%20grades%20and%20anatomic%20sites&journal=Clin.%20Cancer%20Res.&doi=10.1158%2F1078-0432.CCR-18-3147&volume=25&pages=2458-2470&publication_year=2019&author=Nassar%2CAH's gross income?
- How profitable is https://www.nature.com/articles/s41591-019-0628-7/articles/cas-redirect/1:CAS:528:DC%2BB3cXnsFCqt7w%3D?
- http://scholar.google.com/scholar_lookup?&title=Erdafitinib%20in%20locally%20advanced%20or%20metastatic%20urothelial%20carcinoma&journal=N.%20Engl.%20J.%20Med.&doi=10.1056%2FNEJMoa1817323&volume=381&pages=338-348&publication_year=2019&author=Loriot%2CY's financial summary
- How much profit is http://scholar.google.com/scholar_lookup?&title=Sample%20size%20tables%20for%20exact%20single-stage%20phase%20II%20designs&journal=Stat.%20Med.&doi=10.1002%2Fsim.721&volume=20&pages=859-866&publication_year=2001&author=A%E2%80%99Hern%2CRP making per month?
- How much does https://citation-needed.springer.com/v2/references/10.1038/s41591-019-0628-7?format=refman&flavour=references pull in monthly?
- Profit of https://www.nature.com/articles/s41591-019-0628-7/search?author=Thomas%20Powles
- How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Thomas%20Powles?
- What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Thomas%20Powles%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Get to know https://www.nature.com/articles/s41591-019-0628-7/search?author=Mark%20Kockx's earnings
- Learn how profitable https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mark%20Kockx is on a monthly basis
- What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mark%20Kockx%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- https://www.nature.com/articles/s41591-019-0628-7/search?author=Alejo%20Rodriguez-Vida's total income per month
- What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Alejo%20Rodriguez-Vida?
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Alejo%20Rodriguez-Vida%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Get to know what's the income of https://www.nature.com/articles/s41591-019-0628-7/search?author=Ignacio%20Duran
- How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ignacio%20Duran earning monthly?
- How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ignacio%20Duran%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
- What's the financial intake of https://www.nature.com/articles/s41591-019-0628-7/search?author=Simon%20J.%20Crabb?
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Simon%20J.%20Crabb?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Simon%20J.%20Crabb%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
- How much profit does https://www.nature.com/articles/s41591-019-0628-7/search?author=Michiel%20S.%20Van%20Der%20Heijden make?
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Michiel%20S.%20Van%20Der%20Heijden?
- What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Michiel%20S.%20Van%20Der%20Heijden%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much cash flow does https://www.nature.com/articles/s41591-019-0628-7/search?author=Bernadett%20Szabados have monthly?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Bernadett%20Szabados bring in?
- What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Bernadett%20Szabados%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Financial intake of https://www.nature.com/articles/s41591-019-0628-7/search?author=Albert%20Font%20Pous
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Albert%20Font%20Pous?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Albert%20Font%20Pous%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
- Check the income stats for https://www.nature.com/articles/s41591-019-0628-7/search?author=Gwenaelle%20Gravis
- What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Gwenaelle%20Gravis?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Gwenaelle%20Gravis%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate monthly?
- How profitable is https://www.nature.com/articles/s41591-019-0628-7/search?author=Urbano%20Anido%20Herranz?
- What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Urbano%20Anido%20Herranz each month?
- Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Urbano%20Anido%20Herranz%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.nature.com/articles/s41591-019-0628-7/search?author=Andrew%20Protheroe generate monthly?
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Andrew%20Protheroe make?
- How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Andrew%20Protheroe%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
- How much profit does https://www.nature.com/articles/s41591-019-0628-7/search?author=Alain%20Ravaud make?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Alain%20Ravaud bring in?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Alain%20Ravaud%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
- What's the monthly money flow for https://www.nature.com/articles/s41591-019-0628-7/search?author=Denis%20Maillet?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Denis%20Maillet bring in?
- How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Denis%20Maillet%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Monthly income for https://www.nature.com/articles/s41591-019-0628-7/search?author=Maria%20Jose%20Mendez
- Monthly income for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Maria%20Jose%20Mendez
- Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Maria%20Jose%20Mendez%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- See how much https://www.nature.com/articles/s41591-019-0628-7/search?author=Cristina%20Suarez makes per month
- Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Cristina%20Suarez
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Cristina%20Suarez%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- What's the revenue for https://www.nature.com/articles/s41591-019-0628-7/search?author=Mark%20Linch?
- What is the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mark%20Linch?
- Discover the revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mark%20Linch%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Find out how much https://www.nature.com/articles/s41591-019-0628-7/search?author=Aaron%20Prendergast earns monthly
- What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Aaron%20Prendergast?
- Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Aaron%20Prendergast%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.nature.com/articles/s41591-019-0628-7/search?author=Pieter-Jan%20van%20Dam make?
- Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Pieter-Jan%20van%20Dam earns monthly
- How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Pieter-Jan%20van%20Dam%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
- How much money does https://www.nature.com/articles/s41591-019-0628-7/search?author=Diana%20Stanoeva generate?
- What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Diana%20Stanoeva?
- Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Diana%20Stanoeva%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much money does https://www.nature.com/articles/s41591-019-0628-7/search?author=Sofie%20Daelemans make?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Sofie%20Daelemans produce monthly?
- What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Sofie%20Daelemans%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the revenue for https://www.nature.com/articles/s41591-019-0628-7/search?author=Sanjeev%20Mariathasan?
- Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Sanjeev%20Mariathasan
- What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Sanjeev%20Mariathasan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What is the earnings of https://www.nature.com/articles/s41591-019-0628-7/search?author=Joy%20S.%20Tea?
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Joy%20S.%20Tea?
- How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Joy%20S.%20Tea%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
- How much profit does https://www.nature.com/articles/s41591-019-0628-7/search?author=Kelly%20Mousa make?
- How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kelly%20Mousa earning monthly?
- What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kelly%20Mousa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Learn about the earnings of https://www.nature.com/articles/s41591-019-0628-7/search?author=Romain%20Banchereau
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Romain%20Banchereau generate monthly?
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Romain%20Banchereau%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- What's the income generated by https://www.nature.com/articles/s41591-019-0628-7/search?author=Daniel%20Castellano each month?
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Daniel%20Castellano
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Daniel%20Castellano%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- What are the total earnings of https://www.nature.com/articles/s41591-019-0628-7/mailto:[email protected]?
- How much does https://www.nature.com/articles/s41591-019-0628-7/articles/s41591-019-0628-7/figures/4 earn?
- How much does https://www.nature.com/articles/s41591-019-0628-7/articles/s41591-019-0628-7/figures/5 bring in each month?
- https://www.nature.com/articles/s41591-019-0628-7/articles/s41591-019-0628-7/figures/6's financial summary
- How much money does https://www.nature.com/articles/s41591-019-0628-7/articles/s41591-019-0628-7/figures/7 generate?
- What are the earnings of https://www.nature.com/articles/s41591-019-0628-7/articles/s41591-019-0628-7/figures/8?
- How much does https://www.nature.com/articles/s41591-019-0628-7/articles/s41591-019-0628-7/figures/9 gross monthly?
- Revenue of https://www.nature.com/articles/s41591-019-0628-7/articles/s41591-019-0628-7/figures/10
- Get to know https://www.nature.com/articles/s41591-019-0628-7/articles/s41591-019-0628-7#ref-CR11's earnings
- What's the revenue for https://static-content.springer.com/esm/art%3A10.1038%2Fs41591-019-0628-7/MediaObjects/41591_2019_628_MOESM1_ESM.pdf?
- What's the profit of https://static-content.springer.com/esm/art%3A10.1038%2Fs41591-019-0628-7/MediaObjects/41591_2019_628_MOESM2_ESM.pdf?
- What's the financial outcome of https://s100.copyright.com/AppDispatchServlet?title=Clinical%20efficacy%20and%20biomarker%20analysis%20of%20neoadjuvant%20atezolizumab%20in%20operable%20urothelial%20carcinoma%20in%20the%20ABACUS%20trial&author=Thomas%20Powles%20et%20al&contentID=10.1038%2Fs41591-019-0628-7©right=The%20Author%28s%29%2C%20under%20exclusive%20licence%20to%20Springer%20Nature%20America%2C%20Inc.&publication=1078-8956&publicationDate=2019-11-04&publisherName=SpringerNature&orderBeanReset=true?
- What's the financial intake of https://crossmark.crossref.org/dialog/?doi=10.1038/s41591-019-0628-7?
- How much does https://citation-needed.springer.com/v2/references/10.1038/s41591-019-0628-7?format=refman&flavour=citation pull in monthly?
- Get to know https://www.nature.com/articles/s41591-019-0628-7/subjects/bladder-cancer's earnings
- How much revenue does https://www.nature.com/articles/s41591-019-0628-7/subjects/predictive-markers bring in?
- What's https://www.nature.com/articles/s41591-019-0645-6's gross income?
- What are the total earnings of https://www.nature.com/npg_/company_info/index.html?
- Learn about the earnings of https://www.nature.com/npg_/press_room/press_releases.html
- How much income is https://press.nature.com/ earning monthly?
- What's the total monthly financial gain of https://support.nature.com/support/home?
- Learn how profitable https://www.nature.com/subjects is on a monthly basis
- What's the monthly money flow for https://www.protocols.io/?
- How much does https://www.natureindex.com/ bring in each month?
- Learn how profitable https://www.nature.com/authors/editorial_policies is on a monthly basis
- https://www.nature.com/nature-research/open-access income
- Income figures for https://www.nature.com/reprints
- How profitable is https://www.springernature.com/gp/authors/research-data?
- Earnings of https://authorservices.springernature.com/language-editing/
- What is the monthly revenue of https://authorservices.springernature.com/scientific-editing/?
- How much does https://masterclasses.nature.com/ rake in every month?
- Revenue of https://solutions.springernature.com/
- Check the income stats for https://www.springernature.com/gp/librarians/tools-services
- What are the earnings of https://www.springernature.com/gp/librarians/manage-your-account/librarianportal?
- Get to know https://www.nature.com/openresearch/about-open-access/information-for-institutions's earnings
- How profitable is https://www.springernature.com/gp/librarians/recommend-to-your-library?
- Earnings of https://partnerships.nature.com/product/digital-advertising/
- How much does https://partnerships.nature.com/ pull in monthly?
- How profitable is https://partnerships.nature.com/media-kits/?
- Check the income stats for https://partnerships.nature.com/product/branded-content-native-advertising/
- Explore the financials of https://www.nature.com/naturecareers/
- How much does https://conferences.nature.com pull in monthly?
- How much does https://www.nature.com/natafrica gross monthly?
- What's the financial intake of http://www.naturechina.com?
- https://www.nature.com/nindia's financial summary
- What's the financial gain of https://www.nature.com/natitaly?
- Get to know what's the income of https://www.natureasia.com/ja-jp
- Check the income stats for https://www.nature.com/nmiddleeast
- What's the income of https://www.nature.com/info/cookies?
- What is the monthly revenue of https://www.nature.com/info/legal-notice?
- What's the income of https://www.nature.com/info/accessibility-statement?
- Monthly income for https://www.nature.com/info/terms-and-conditions
- Find out how much https://www.springernature.com/ccpa earns monthly
- How much does https://www.springernature.com/ make?
- How much money does https://www.nature.com/briefing/signup/?brieferEntryPoint=MainBriefingBanner make?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Prism.js
- Zoom.js
Emails and Hosting {✉️}
Mail Servers:
- mx.zoho.eu
- mx2.zoho.eu
- mx3.zoho.eu
Name Servers:
- josh.ns.cloudflare.com
- zita.ns.cloudflare.com
CDN Services {📦}
- Crossref